Literature DB >> 13803557

Carbimazole (neo-mercazole) in thyrotoxicosis--a review of sixty patients.

M W BOYD.   

Abstract

Entities:  

Keywords:  HYPERTHYROIDISM/therapy; THYROID ANTAGONISTS/therapy

Mesh:

Substances:

Year:  1959        PMID: 13803557      PMCID: PMC2384519     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


× No keyword cloud information.
  22 in total

1.  Fatal marrow aplasia after treatment with carbimazole.

Authors:  C D BURRELL
Journal:  Br Med J       Date:  1956-06-23

2.  Clinical experiences with carbimazole (1-methyl-2-carbethoxy-thio-imidazole) in the treatment of hyperthyroidism.

Authors:  T H MCGAVACK; J CHEVALLEY; H K RECKENDORF; H O HAAR
Journal:  J Clin Endocrinol Metab       Date:  1956-07       Impact factor: 5.958

3.  Carbimazole in thyrotoxicosis.

Authors:  K KIRKEBY; O RØMCKE
Journal:  Lancet       Date:  1955-02-18       Impact factor: 79.321

4.  Antithyroid activity and toxicity of mercazole and neo-mercazole.

Authors:  T R FRASER; O GARROD; M G HANNO; A JADRESIC
Journal:  J Clin Endocrinol Metab       Date:  1954-10       Impact factor: 5.958

5.  Agranulocytosis in a patient treated with carbimazole.

Authors:  A R HARRISON
Journal:  Lancet       Date:  1954-02-20       Impact factor: 79.321

6.  Fatal case of marrow aplasia after treatment with carbimazole; the effect of ACTH.

Authors:  J S RICHARDSON; I SARKANY; C D CAMPBELL
Journal:  Br Med J       Date:  1954-02-13

7.  Anti-thyroid activity of 2-carbethoxythio-1-methylglyoxaline.

Authors:  A G MACGREGOR; H MILLER
Journal:  Lancet       Date:  1953-05-02       Impact factor: 79.321

8.  Treatment of thyrotoxicosis with 2-carbethoxythio-1-methylglyoxaline (C.G.1).

Authors:  A LAWSON; G BARRY
Journal:  Lancet       Date:  1951-10-06       Impact factor: 79.321

9.  Long-term therapy of thyrotoxicosis with thiouracil compounds.

Authors:  J F GOODWIN; H STEINBERG; A WILSON
Journal:  Br Med J       Date:  1954-02-20

10.  Late results from continuous treatment of thyrotoxicosis with methylthiouracil.

Authors:  K IVERSEN
Journal:  J Clin Endocrinol Metab       Date:  1951-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.